Investment
Features
FeesSafety
Academy
More
Pluang+

Graphite One advances U.S. graphite supply chain with Alaska mine and Ohio manufacturing plans

Market News
19 Oct 2026
PRNewsWire
View Source
Bullish
Graphite One advances U.S. graphite supply chain with Alaska mine and Ohio manufacturing plans

Graphite One Inc. is developing the Graphite Creek Project in Alaska, aiming to build a domestic U.S. graphite supply chain. The project is recognized as a major national security asset due to its large graphite deposit, supported by U.S. Department of Defense grants. The company plans to mine and process graphite in Alaska and manufacture advanced graphite materials in Ohio, reducing U.S. reliance on foreign graphite sources. This integrated approach includes potential recycling and aims to support the electric vehicle and energy storage markets.

Graphite One's Alaska Graphite Creek Project is the subject here, with Pluang providing a sector snapshot for context. Of 83 Basic Materials-sector US stocks priced on Pluang, 44 rose and 29 fell today. Notable movers include Element Solutions Inc. (ESI) at USD 35.52 with a +1.34% change, Franco-Nevada Corporation (FNV) at USD 240.72 with a -1.23% change, and Century Aluminum Company (CENX) at USD 35.45 with a +1.20% change, as of Oct 19, 2026 18:11 WIB.

More News

Lexeo Therapeutics to host event on clinical measures in PKP2 arrhythmogenic cardiomyopathy

Lexeo Therapeutics to host event on clinical measures in PKP2 arrhythmogenic cardiomyopathy

Lexeo Therapeutics announced an educational event on October 21, 2026, focusing on clinical endpoints and outcome measures in PKP2 arrhythmogenic cardiomyopathy (PKP2-ACM). The event will feature discussions by Lexeo's Chief Medical Officer and a lea...

Others
Neutral
24 minutes ago
EyePoint's DURAVYU misses primary endpoint in wet AMD trial but shows reduced treatment burden and safety.

EyePoint's DURAVYU misses primary endpoint in wet AMD trial but shows reduced treatment burden and safety.

EyePoint announced that its DURAVYU treatment for wet age-related macular degeneration (wet AMD) did not meet the primary goal of matching the visual improvement of the standard aflibercept treatment in the LUCIA Phase 3 trial. However, DURAVYU demon...

Company Fundamentals
Neutral
24 minutes ago
Marker Therapeutics wins $2.6M FDA grant to advance MT-601 therapy for pancreatic cancer.

Marker Therapeutics wins $2.6M FDA grant to advance MT-601 therapy for pancreatic cancer.

Marker Therapeutics has been awarded a $2.6 million grant from the FDA's Orphan Products Clinical Trials program to support a Phase 1 study of its MT-601 multi-antigen recognizing T cell therapy for locally advanced unresectable pancreatic cancer. Th...

Market News
Bullish
24 minutes ago
Agility Robotics appoints Mark Vale as audit committee chair ahead of public listing.

Agility Robotics appoints Mark Vale as audit committee chair ahead of public listing.

Agility Robotics announced that Mark Vale, former UPS president and current CEO of Transportation Insight, will join its board and chair the audit committee after its merger with Churchill Capital Corp XI. Vale's extensive experience in global logist...

Company Fundamentals
Bullish
24 minutes ago
JazzCash wins Silver Award for innovation in InsurTech at Money20/20 USA 2026

JazzCash wins Silver Award for innovation in InsurTech at Money20/20 USA 2026

JazzCash, Pakistan's leading digital financial services platform, won the Silver Award in the Banking – InsurTech category at Money20/20 USA 2026 for its health-protection platform Sehat+. This platform provides affordable health insurance to Pakista...

Market News
Bullish
24 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App